価格表

在庫・価格 : 2024年04月29日 07時10分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SARS-CoV-2 (COVID-19) Spike, Rabbit-Poly
データシート
GTX135356 GNTジーンテックス
GeneTex International Corporation
100 μl ¥75,000 1個 追加

在庫・価格 : 2024年04月29日 07時10分 現在

Anti-SARS-CoV-2 (COVID-19) Spike, Rabbit-Poly

  • 商品コード:GTX135356
  • メーカー:GNT
  • 包装:100μl
  • 価格: ¥75,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Garc鱈a-Arriaza J et al. COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice. J Virol 2021 Jan;
Garc鱈a-Arriaza J et al
2021/01/01
PubMed
2 Sukhikh G et al., Sukhikh G, Viruses, 2021

PubMed
3 . Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol 2021 05;6(59)

2021/01/01
PubMed
4 Sukhikh G et al. Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology. Viruses 2021 03;13(3)
Sukhikh G et al
2021/01/01
PubMed
5 Harbour JC et al. Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein. J Immunol 2021 06;206(11):2596-2604
Harbour JC et al
2021/01/01
PubMed
6 Yang B et al. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry. Proc Natl Acad Sci U S A 2022 01;119(4)
Yang B et al
2022/01/01
PubMed
7 Huang HC et al. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine 2021 Dec;74:103712
Huang HC et al
2021/01/01
PubMed
8 Ordonez AA et al. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun Biol 2022 Mar;5(1):242
Ordonez AA et al
2022/01/01
PubMed
9 Meseda CA et al. MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge. NPJ Vaccines 2021 Dec;6(1):145
Meseda CA et al
2021/01/01
PubMed
10 Lin WS et al. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants. Front Immunol 2021;12:795741
Lin WS et al
2021/01/01
PubMed
11 Hsieh MH et al. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Front Immunol 2021;12:641360
Hsieh MH et al
2021/01/01
PubMed
12 Routhu NK et al. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity 2021 Mar;54(3):542-556.e9
Routhu NK et al
2021/01/01
PubMed
13 V叩squez V et al. SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex. Anal Chim Acta 2022 May;1205:339718
V叩squez V et al
2022/01/01
PubMed
14 Zeng W et al. Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2. Front Cell Infect Microbiol 2022;12:911313
Zeng W et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Garc鱈a-Arriaza J et al. COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice. J Virol 2021 Jan;
    Garc鱈a-Arriaza J et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sukhikh G et al., Sukhikh G, Viruses, 2021

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    . Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol 2021 05;6(59)

    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Sukhikh G et al. Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology. Viruses 2021 03;13(3)
    Sukhikh G et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Harbour JC et al. Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein. J Immunol 2021 06;206(11):2596-2604
    Harbour JC et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Yang B et al. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry. Proc Natl Acad Sci U S A 2022 01;119(4)
    Yang B et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Huang HC et al. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine 2021 Dec;74:103712
    Huang HC et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ordonez AA et al. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun Biol 2022 Mar;5(1):242
    Ordonez AA et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Meseda CA et al. MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge. NPJ Vaccines 2021 Dec;6(1):145
    Meseda CA et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Lin WS et al. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants. Front Immunol 2021;12:795741
    Lin WS et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Hsieh MH et al. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Front Immunol 2021;12:641360
    Hsieh MH et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Routhu NK et al. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity 2021 Mar;54(3):542-556.e9
    Routhu NK et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    V叩squez V et al. SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex. Anal Chim Acta 2022 May;1205:339718
    V叩squez V et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Zeng W et al. Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2. Front Cell Infect Microbiol 2022;12:911313
    Zeng W et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed